Jump to content

Hope for us all - Source of baldness discovered: Prostaglandin D2 Linked to Hair Loss


England

Recommended Posts

  • Senior Member

Scientists pinpoint protein linked to baldness

 

Hair Loss Cure? Recent Discovery of PGD2 (Prostaglandin D2) Brings Hope For Ending Hair Loss

 

Scientists have discovered a protein linked to male baldness, which could pave the way for new treatments for hair loss in men.

Researchers from the University of Pennsylvania found that men with male pattern baldness have three times more of a protein called prostaglandin D2 (PDG2) in the bald patches of their scalps compared with other parts still with hair.

The protein is thought to work by stopping the growth of hair follicle stem cells in the scalp, responsible for hair growth. This means that treatments to suppress the production of PDG2 could potentially be used to prevent hair loss in men.

Male pattern baldness affects eight out of 10 men under the age of 70, and causes hair follicles to shrink and produce microscopic hairs.

A previous study found that bald areas of the scalp contain the same number of stem cells as normal hair-growing parts of the scalp in the same person, but contain fewer mature cells.

This suggested that the scalp was lacking an activator or something was inhibiting hair follicle stem cells from growing.

In this study, researchers looked at samples of scalp tissue from balding and non-bald spots of more than 20 men with male pattern baldness. Levels of PGD2 were found to be three times higher in the bald patches compared with areas where hair was still growing.

This was also confirmed at the genetic level; PGD2 genes were shown to be more active in bald tissue samples.

When PGD2 was added to hair follicles cultured in the lab, it was "significantly shorter," the study found.

They authors wrote: "Our findings should lead directly to new treatments for the most common cause of hair loss in men.

"The potential for developing these compounds into topical formulations for treating AGA (androgenic alopecia) should elicit great interest moving forward."

The study is published in Science Translational Medicine.

Link to comment
Share on other sites

  • Senior Member

I saw that yesterday on the news.

 

Nice to see it brought up in the news and hopefully one day :)

2 poor unsatisfactory hair transplants performed in the UK.

 

Based on vast research and meeting patients, I travelled to see Dr Feller in New York to get repaired.

Link to comment
Share on other sites

  • Senior Member

Update from our Hair Loss Q & A blog:

 

Scientists Identify Hair Loss Molecule? "Prostaglandin D2" Linked to Androgenic Alopecia.

 

It's always nice to see progress!

"Doc" Blake Bloxham - formerly "Future_HT_Doc"

 

Forum Co-Moderator and Editorial Assistant for the Hair Transplant Network, the Hair Loss Learning Center, the Hair Loss Q&A Blog, and the Hair Restoration Forum

 

All opinions are my own and my advice does not constitute as medical advice. All medical questions and concerns should be addressed by a personal physician.

Link to comment
Share on other sites

  • Senior Member

I think this find is "significant" . They now "know" the protein responsible. If they can target that protein somehow then that drug could become the superdrug to combat hairloss.

Link to comment
Share on other sites

  • 2 weeks later...

To add more clarity (or confusion), this research seems to confirm the role of activators and inhibitors prostaglandins exhibit in relation to hair growth in mice and humans. Prostaglandin F2α's analogous is already included in the FDA-approved topical drug Latisse(Bimatoprost) as a cosmetic eyelash-strengthener and testing is in progress of the effectiveness of higher doses of such drug in human hair loss cases. Just like prostaglandin F2α has exhibited the role of activator in the growth and multiplication of hair follicles, the newly studied prostaglandin D2 has undoubtedly shown its role as hair growth inhibitor.

 

The true good news is that prostaglandins exhibit a multitude of different roles unrelated to hair loss and prostaglandin D2 in particular has already been correlated with ashtma. This means drugs which target prostaglandin D2's receptor are already being tested.

Edited by Aldebaran
Link to comment
Share on other sites

  • Senior Member

This is really interesting. Hopefully it won't be too long since the drug Diclofenac (Voltarol) is an anti inflammatory that inhibits PGD2 already exists so they can test it. In addition it comes as a topical gel for the treatment of muscular and joint pain. Maybe they will trial it??

_________________________________________________

Propecia since July 2008

2201 Grafts with Dr Lorenzo on 19.10.22 - See my write up here:

 

Link to comment
Share on other sites

I presume the final drug based on this research would be composed by a combination of prostaglandins... a mix of growth agents and inhibitors of inhibiting agents. Allergan has been testing bimatoprost since 2010 (Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia - Full Text View - ClinicalTrials.gov), but i can't seem to find any recent news, other than a mention on Dr.Bauman's blog that testing is indeed in progress.

Link to comment
Share on other sites

  • Senior Member

Just a thought, but the mechanism behind aspirin's function is the inhibition of Prostaglandin. Perhaps the low dosage 75mg a day (often prescribed for preventitive cardiovascular health) could be of benefit in fighting MPB alongside other treatments. A quick Google suggests that Aspirin inhibits Prostaglandin D2 as well as other forms.

 

Any thoughts on this?

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...